HealthAI imageUS FDA Launches Expedited IND Pilot to Speed Clinical Trials
The US Food and Drug Administration (FDA) has announced the final design of its Expedited Investigational New Drug (IND) Pilot program. This initiative aims to accelerate clinical trial timelines and remove regulatory hurdles, facilitating faster drug development and approval processes.
Pharma Biz·


